Objective Cardiovascular diseases (CVD) remain the leading cause of mortality globally, necessitating early risk ...
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...
Camrelizumab combined with rivoceranib and TACE in the perioperative treatment of hepatocellular carcinoma: A randomized, open-label multicenter trial. This is an ASCO Meeting Abstract from the 2025 ...
NEW YORK & TEL AVIV, Israel--(BUSINESS WIRE)--Pecan AI, the leader in AI-based predictive analytics for BI analysts and business teams, today announced that it has opened its predictive analytics ...
Appa Rao Nagubandi's research advocates for autonomous predictive agents and low-latency analytics to enable real-time P&L ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results